Nazan Has Selmi

Dr. Nazan Has Selmi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in COVID
Verified
Journal Article
Open access
PDF file
DCDuygu Kayar Calili
Duygu Kayar Calili
PUPınar Ulubaşoğlu
Pınar Ulubaşoğlu
ETErol Toy
Erol Toy
DBDemet Bolukbasi
Demet Bolukbasi
MKMeryem Keleş
Meryem Keleş
SISeval Izdes
Seval Izdes
Although acute kidney injury (AKI) is common among patients with coronavirus disease 2019 (COVID-19), there are only limited data on its occurrence at intensive care unit (ICU) admission. Assessing the factors associated with AKI is essential for early diagnosis and intervention. This study aims to compare the clinical and laboratory characteristics and survival outcomes of COVİD-19 patients with and without AKI at ICU admission and determine the factors associated with AKI. In this study, patients with SARS-CoV-2 infection were categorized based on the presence (AKI group) or absence (non-AKI group) of AKI. Clinical and laboratory data and outcomes were analyzed retrospectively. Of the 712 patients included in this study, 198 were assigned to the AKI group and 514 were assigned to the non-AKI group. Patients with AKI had more comorbidities and higher disease severity; higher rates of invasive mechanical ventilation, vasopressor therapy, and mortality; and longer hospital stays (p < 0.05). Our multivariate analysis identified advanced age, a high Acute Physiology and Chronic Health Evaluation II score, a high neutrophil-to-lymphocyte ratio, a low albumin level, and the presence of comorbidities as independent factors associated with AKI. In patients with COVID-19, AKI observed at ICU admission is associated with advanced age and increased disease severity. The early diagnosis and monitoring of patients may improve clinical outcomes.

12 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
NŞNilgün Şahin
Nilgün Şahin
SASemih Aydemir
Semih Aydemir
NSNazan Has Selmi
Nazan Has Selmi
İEİbrahim Ertaş
İbrahim Ertaş
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
MEMESHER ENSARİOGLU
MESHER ENSARİOGLU
Background/Objectives: This study aimed to investigate the prognostic significance of the triglyceride–glucose index (TGI), triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio, and inflammatory biomarkers in predicting short-term mortality among intensive care unit (ICU) patients with sepsis. Additionally, this study evaluated whether combining these indices with conventional clinical scores improves prognostic accuracy. Methods: This retrospective cohort study included 600 adult ICU patients diagnosed with sepsis according to Sepsis-3 criteria between January 2020 and April 2025. Clinical, biochemical, and hematological data were collected within the first 24 h of ICU admission. Metabolic indices (TGI, TG/HDL-C) and inflammatory markers (neutrophil-to-lymphocyte ratio [NLR], systemic immune-inflammation index [SII], and pan-immune-inflammation value [PIV]) were analyzed. The primary outcome was 28-day mortality. Receiver operating characteristic (ROC) analyses, Kaplan–Meier survival curves, and a multivariable logistic regression model were applied to determine prognostic performance. Results: Non-survivors exhibited significantly higher levels of TGI, TG/HDL-C, NLR, SII, and PIV compared to survivors (all p < 0.001). In ROC analysis, TGI (AUC = 0.75, 95% CI: 0.71–0.79), TG/HDL-C (AUC = 0.72, 95% CI: 0.68–0.76), and PIV (AUC = 0.78, 95% CI: 0.74–0.82) demonstrated good discriminative power for predicting 28-day mortality. Multivariate logistic regression identified TGI > 8.95 (OR = 1.44, 95% CI: 1.19–1.74, p < 0.001), TG/HDL-C > 3.95 (OR = 1.31, 95% CI: 1.08–1.59, p = 0.005), and PIV > 260 (OR = 1.49, 95% CI: 1.22–1.82, p < 0.001) as independent predictors of mortality. Integrating TGI and PIV with the SOFA score improved prognostic performance (ΔAUC = +0.04). Conclusions: Both TGI and TG/HDL-C are independent predictors of short-term mortality in septic ICU patients, reflecting the contribution of metabolic dysregulation to disease severity. The PIV demonstrated comparable predictive ability to conventional severity scores. Combining metabolic and inflammatory biomarkers with established clinical indices may enhance early risk stratification and guide personalized management strategies in sepsis.

21 April 2025 in COVID
Verified
Journal Article
Open access
PDF file
Ferhat SoykanFerhat Soykan
Ferhat Soykan
DBDemet Bolukbasi
Demet Bolukbasi
ETErol Toy
Erol Toy
NSNazan Has Selmi
Nazan Has Selmi
AYAsiye Yavuz
Asiye Yavuz
SISeval Izdes
Seval Izdes
Serum ferritin levels increase in severe COVID-19 patients. However, few data correlating the sensitivity and specificity of ferritin levels and mortality prediction in COVID-19 exist. The current study aims to investigate the sensitivity and specificity of ferritin for the prediction of mortality risks relative to COVID-19. Retrospectively, critically ill COVID-19 patients admitted to the general intensive care unit (ICU) of Ankara Bilkent City Hospital, Türkiye, were examined. The median baseline ferritin level in the survivor group was 184.7 µg/L (90.1–430.7), while it was 297.0 µg/L (150.3–851.3) in the deceased group (p = 0.001). The median maximum ferritin in the survivor group was 486.6 µg/L (187.9–1020.0), while it was 1456.7 µg/L (578.5–4388.1) in the deceased group (p < 0.001). In the receiver operating characteristic (ROC) curve analysis, the cut-off baseline ferritin value was 201.5 µg/L for the prediction of mortality (area under the curve [AUC] = 0.615, p < 0.001, 95% Confidence interval [CI]: 0.557–0.671). Baseline ferritin levels were associated with increased in-hospital mortality (p < 0.001, odds ratio: 2.347, 95% CI: 1.5–3.7). Baseline ferritin exhibited 66% sensitivity and 54.2% specificity in predicting mortality. The maximum ferritin cut-off value was 878.6 µg/L (AUC = 0.754, p < 0.001, 95% CI: 0.701–0.802), exhibiting 68% sensitivity and 73.2% specificity for mortality prediction. Ferritin has a moderately effective prediction potential for mortality in COVID-19 patients admitted to the ICU.